Sabra Health Care Reit, INC 8-K filings

Sabra Health Care REIT announced a business update, including a significant re-tenanting of 26 Avamere properties and increased full-year 2026 guidance.

Sabra Health Care REIT, Inc. announced the results of its annual meeting, including the election of directors and ratification of its auditor.

Sabra Health Care REIT provides a strategic update on its portfolio, investment activity, and balance sheet strength as of May 2026.

Sabra Health Care REIT, Inc. announced robust first quarter 2026 results, driven by strong operational performance and strategic investments, while reiterating its full-year guidance.

Sabra Health Care REIT, Inc. announced robust fourth-quarter 2025 results and introduced optimistic 2026 guidance, driven by strong investment activity and operational improvements across its portfolio.

Sabra Health Care REIT, Inc. announced the appointment of Darrin Smith as Chief Investment Officer, Secretary, and Executive Vice President, succeeding the retiring Talya Nevo-Hacohen.

Sabra Health Care REIT reports strong Q3 2025 results, raises full-year guidance, and receives a credit rating upgrade from Moodys, signaling robust operational performance and strategic growth.

Sabra Health Care REIT, Inc. has established a new At-The-Market equity offering program for up to $750 million, replacing its prior $500 million program.

Sabra Health Care REIT reports robust second-quarter 2025 results, exceeding prior year performance and updating its full-year guidance positively, driven by strategic investments and improved operational metrics.

Sabra Health Care REIT, Inc. secured a new $500 million unsecured term loan and simultaneously redeemed its 2026 Senior Notes, optimizing its debt structure.

Sabra Health Care Limited Partnership, a subsidiary of Sabra Health Care REIT, Inc., announced it will redeem all $500 million of its 5.125% Senior Notes due 2026 on July 31, 2025, funded by a new $500 million term loan.

Sabra Health Care REIT, Inc. announced that its stockholders overwhelmingly approved all proposals at the annual meeting on June 12, 2025, including the election of seven directors, ratification of PricewaterhouseCoopers LLP as auditor, and advisory approval of executive compensation.

Sabra Health Care REIT announced its Q1 2025 results, highlighting growth in the senior housing managed portfolio and reaffirming its 2025 guidance.

Talya Nevo-Hacohen, Sabra's Chief Investment Officer, will retire effective December 31, 2025, with Darrin Smith expected to take over the position on January 1, 2026, and Ms. Nevo-Hacohen will remain in a consulting role.

Sabra Health Care REIT announces positive Q4 2024 results, driven by strong operator performance and strategic portfolio management, while also introducing promising 2025 earnings guidance.

Clifton J. Porter II will not seek reelection to Sabra Health Care REIT's board of directors at the 2025 annual meeting.

Sabra Health Care REIT announced positive third-quarter 2024 results, highlighted by increased same-store cash NOI and updated full-year earnings guidance.

Sabra Health Care REIT announced positive second quarter results for 2024, driven by improvements in skilled nursing and senior housing, leading to an increase in their full-year earnings guidance.

Sabra Health Care REIT held its annual meeting on June 13, 2024, where stockholders elected directors, ratified the auditor, and approved executive compensation on an advisory basis.

Sabra Health Care REIT announced its first quarter 2024 results, showing improvements in key portfolio metrics and reiterating its full-year 2024 guidance.

Sabra Health Care REIT announced its fourth quarter 2023 results, showing improvements in occupancy and rent coverage, and introduced its 2024 earnings guidance.